SlideShare a Scribd company logo
Disease Incidence Prevention by Serum 25(OH)D Level
Serum 25(OH)D, ng/ml 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42 44 46 48 50 52 54 56 58 60 62 64 66 68
Studies of Individuals
Cancers, all combined
Breast Cancer X X X X X X X X
Ovarian Cancer
Colon Cancer X X X X
Non-Hodgkins Lymphoma
Type 1 Diabetes
Fractures, all combined
Falls, women
Multiple Sclerosis X X X
Heart Attack (Men)
Natural Experiments
Kidney Cancer
Endometrial Cancer
Rickets
X X X
X X X X
72%
50%
99%
37%
23% 49%
12% 17%
25% 66%
25%
12% 18%
31% 38% 60%
77% with calcium
Legend:
All percentages reference a common baseline of 25 ng/ml as shown on the chart.
%’s reflect the disease prevention % at the beginning and ending of available data.
Example: Breast cancer incidence is reduced by 30% when the serum level is 34 ng/ml vs the baseline of 25 ng/ml.
There is an 83% reduction in incidence when the serum level is 50 ng/ml vs the baseline of 25 ng/ml.
The x’s in the bars indicate ‘reasonable extrapolations’ from the data but are beyond existing data.
References:
All Cancers: Lappe JM, et al. Am J Clin Nutr. 2007;85:1586-91. Breast: Garland CF, Gorham ED, Mohr SB, Grant WB, Garland FC. Breast cancer risk according to serum 25-Hydroxyvitamin D: Meta-analysis of Dose-Response
(abstract).American Association for Cancer Research Annual Meeting, 2008. Reference serum 25(OH)D was 5 ng/ml. Garland, CF, et al. Amer Assoc Cancer Research Annual Mtg, April 2008,. Colon: Gorham ED, et al. Am J Prev
Med. 2007;32:210-6. Diabetes: Hyppönen E, et al. Lancet 2001;358:1500-3. Endometrium: Mohr SB, et al. Prev Med. 2007;45:323-4. Falls: Broe KE, et al. J Am Geriatr Soc. 2007;55:234-9. Fractures: Bischoff-Ferrari HA, et al. JAMA.
2005;293:2257-64. Heart Attack: Giovannucci et al. Arch Intern Med/Vol 168 (No 11) June 9, 2008. Multiple Sclerosis: Munger KL, et al. JAMA. 2006;296:2832-8. Non-Hodgkin’s Lymphoma: Purdue MP, et al. Cancer Causes Control.
2007;18:989-99. Ovary: Tworoger SS, et al. Cancer Epidemiol Biomarkers Prev. 2007;16:783-8. Renal: Mohr SB, et al. Int J Cancer. 2006;119:2705-9. Rickets: Arnaud SB, et al. Pediatrics. 1976 Feb;57(2):221-5. Canadians: Janz T.
Pearson C. Vitamin D blood levels of Canadians. Statistics Canada. 2013 January; ISSN 1925-6493. US: Al-khalidi et al., Standardized serum 25-hydroxyvitamin D concentrations are inversely associated with cardiometabolic disease
in U.S. adults: a cross-sectional analysis of NHANES, 2001-2010. Nutrition Journal. 2017, 16:16. Tribal Africans: Luxwolda M.F. et al. Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration
of 115 nmol/L. Br J Nutr. 2012 November; 108(9):1557-61. Outdoor Workers: Barger-Lux M.J. Heaney R.P. Effects of Above Average Summer Sun Exposure on Serum 25-Hydroxyvitamin D and Calcium Absorption. J Clin Endocrinol
Metab. 2002 November. 87(11):4952-6
33% 54%46%
SerumReferenceLevel
Chart prepared by: Garland CF, Baggerly CACopyright GrassrootsHealth, 05/11/2017 www.grassrootshealth.net
30% 83%
50%
30%
X X X X X X X X
40-60 ng/ml suggested range
Serum Level
1
Only Rickets Prevented
at 20 ng/ml
2
40-60 ng/ml to Prevent
Majority of Diseases
3
US & Canadian Average Outdoor Workers
in Late Summer
Tribal East
Africans

More Related Content

What's hot

Hypercalcemia of malignancy
Hypercalcemia of malignancyHypercalcemia of malignancy
Hypercalcemia of malignancy
medicaldump
 
Publications and Presentations
Publications and PresentationsPublications and Presentations
Publications and PresentationsLin Wang
 
Dr. Donald Lloyd-Jones' Slides from the Heart Innovation Forum (10-25-2013)
Dr. Donald Lloyd-Jones' Slides from the Heart Innovation Forum (10-25-2013)Dr. Donald Lloyd-Jones' Slides from the Heart Innovation Forum (10-25-2013)
Dr. Donald Lloyd-Jones' Slides from the Heart Innovation Forum (10-25-2013)Anne Miller
 
Jennifer Tremmel - Sex Differences In Cardiovascular Disease
Jennifer Tremmel - Sex Differences In Cardiovascular DiseaseJennifer Tremmel - Sex Differences In Cardiovascular Disease
Jennifer Tremmel - Sex Differences In Cardiovascular DiseaseClayman Institute
 
Systemic Inflammation and Cognitive Impairment: Annual Update
Systemic Inflammation and Cognitive Impairment: Annual UpdateSystemic Inflammation and Cognitive Impairment: Annual Update
Systemic Inflammation and Cognitive Impairment: Annual Update
UC San Diego AntiViral Research Center
 
Diet and physical activity in preventing cancer
Diet and physical activity in preventing cancerDiet and physical activity in preventing cancer
Diet and physical activity in preventing cancer
mercifulcrook7974
 
Olorunlana taiwo justice
Olorunlana taiwo justice Olorunlana taiwo justice
Olorunlana taiwo justice
Lynn University
 
Graft versus Tumour effect
Graft versus Tumour effectGraft versus Tumour effect
Graft versus Tumour effectmeducationdotnet
 
Abed_et_al-2013-Obesity_Reviews
Abed_et_al-2013-Obesity_ReviewsAbed_et_al-2013-Obesity_Reviews
Abed_et_al-2013-Obesity_ReviewsHany Abed
 
Chronic kidney disease and old age
Chronic kidney disease and old ageChronic kidney disease and old age
Chronic kidney disease and old age
JimRitchie14
 
Donor Lymphocyte Infusion in Patients with Hematological Malignancies after T...
Donor Lymphocyte Infusion in Patients with Hematological Malignancies after T...Donor Lymphocyte Infusion in Patients with Hematological Malignancies after T...
Donor Lymphocyte Infusion in Patients with Hematological Malignancies after T...spa718
 
International Journal of Gerontology & Geriatric Research
International Journal of Gerontology & Geriatric ResearchInternational Journal of Gerontology & Geriatric Research
International Journal of Gerontology & Geriatric Research
SciRes Literature LLC. | Open Access Journals
 
Donor Lymphocyte Infusion: Dr. Chenhua Yan
Donor Lymphocyte Infusion: Dr. Chenhua YanDonor Lymphocyte Infusion: Dr. Chenhua Yan
Donor Lymphocyte Infusion: Dr. Chenhua Yan
spa718
 
Protocol nlr and plr version 1.0
Protocol nlr and plr version 1.0Protocol nlr and plr version 1.0
Protocol nlr and plr version 1.0gwendolynliow
 
Ueda2015 dm cancer_dr.hala aly
Ueda2015 dm  cancer_dr.hala alyUeda2015 dm  cancer_dr.hala aly
Ueda2015 dm cancer_dr.hala alyueda2015
 
Chronic disease what comes after risk factor epidemiology
Chronic disease what comes after risk factor epidemiologyChronic disease what comes after risk factor epidemiology
Chronic disease what comes after risk factor epidemiology
emphemory
 

What's hot (18)

Hypercalcemia of malignancy
Hypercalcemia of malignancyHypercalcemia of malignancy
Hypercalcemia of malignancy
 
MLGG_for_linkedIn
MLGG_for_linkedInMLGG_for_linkedIn
MLGG_for_linkedIn
 
Publications and Presentations
Publications and PresentationsPublications and Presentations
Publications and Presentations
 
Dr. Donald Lloyd-Jones' Slides from the Heart Innovation Forum (10-25-2013)
Dr. Donald Lloyd-Jones' Slides from the Heart Innovation Forum (10-25-2013)Dr. Donald Lloyd-Jones' Slides from the Heart Innovation Forum (10-25-2013)
Dr. Donald Lloyd-Jones' Slides from the Heart Innovation Forum (10-25-2013)
 
Jennifer Tremmel - Sex Differences In Cardiovascular Disease
Jennifer Tremmel - Sex Differences In Cardiovascular DiseaseJennifer Tremmel - Sex Differences In Cardiovascular Disease
Jennifer Tremmel - Sex Differences In Cardiovascular Disease
 
Systemic Inflammation and Cognitive Impairment: Annual Update
Systemic Inflammation and Cognitive Impairment: Annual UpdateSystemic Inflammation and Cognitive Impairment: Annual Update
Systemic Inflammation and Cognitive Impairment: Annual Update
 
Diet and physical activity in preventing cancer
Diet and physical activity in preventing cancerDiet and physical activity in preventing cancer
Diet and physical activity in preventing cancer
 
Olorunlana taiwo justice
Olorunlana taiwo justice Olorunlana taiwo justice
Olorunlana taiwo justice
 
Graft versus Tumour effect
Graft versus Tumour effectGraft versus Tumour effect
Graft versus Tumour effect
 
Abed_et_al-2013-Obesity_Reviews
Abed_et_al-2013-Obesity_ReviewsAbed_et_al-2013-Obesity_Reviews
Abed_et_al-2013-Obesity_Reviews
 
CANCER MORTALITY PUBLISHED
CANCER MORTALITY PUBLISHEDCANCER MORTALITY PUBLISHED
CANCER MORTALITY PUBLISHED
 
Chronic kidney disease and old age
Chronic kidney disease and old ageChronic kidney disease and old age
Chronic kidney disease and old age
 
Donor Lymphocyte Infusion in Patients with Hematological Malignancies after T...
Donor Lymphocyte Infusion in Patients with Hematological Malignancies after T...Donor Lymphocyte Infusion in Patients with Hematological Malignancies after T...
Donor Lymphocyte Infusion in Patients with Hematological Malignancies after T...
 
International Journal of Gerontology & Geriatric Research
International Journal of Gerontology & Geriatric ResearchInternational Journal of Gerontology & Geriatric Research
International Journal of Gerontology & Geriatric Research
 
Donor Lymphocyte Infusion: Dr. Chenhua Yan
Donor Lymphocyte Infusion: Dr. Chenhua YanDonor Lymphocyte Infusion: Dr. Chenhua Yan
Donor Lymphocyte Infusion: Dr. Chenhua Yan
 
Protocol nlr and plr version 1.0
Protocol nlr and plr version 1.0Protocol nlr and plr version 1.0
Protocol nlr and plr version 1.0
 
Ueda2015 dm cancer_dr.hala aly
Ueda2015 dm  cancer_dr.hala alyUeda2015 dm  cancer_dr.hala aly
Ueda2015 dm cancer_dr.hala aly
 
Chronic disease what comes after risk factor epidemiology
Chronic disease what comes after risk factor epidemiologyChronic disease what comes after risk factor epidemiology
Chronic disease what comes after risk factor epidemiology
 

Similar to Vit D Disease incidence prev chart 051317

Vit D Chart booklet may2016
Vit D Chart booklet may2016Vit D Chart booklet may2016
Vit D Chart booklet may2016
JA Larson
 
Vit D Mrip chart-booklet-08-2018
Vit D Mrip chart-booklet-08-2018Vit D Mrip chart-booklet-08-2018
Vit D Mrip chart-booklet-08-2018
JA Larson
 
Differences in clinical characteristics and its effect for outcomes
Differences in clinical characteristics and its effect for outcomesDifferences in clinical characteristics and its effect for outcomes
Differences in clinical characteristics and its effect for outcomes
drucsamal
 
ueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammedueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammed
ueda2015
 
Update in oncology
Update in oncologyUpdate in oncology
Update in oncology
Prof. Shad Salim Akhtar
 
Dyslipidemia -Assessment and management based on evidence
Dyslipidemia -Assessment and management based on evidence  Dyslipidemia -Assessment and management based on evidence
Dyslipidemia -Assessment and management based on evidence
SYEDRAZA56411
 
Gastrointestinal-Pancreatic NET management
Gastrointestinal-Pancreatic NET managementGastrointestinal-Pancreatic NET management
Gastrointestinal-Pancreatic NET management
Chandan K Das
 
VTE and Cancer Healthcare Professional Education
VTE and Cancer Healthcare Professional EducationVTE and Cancer Healthcare Professional Education
VTE and Cancer Healthcare Professional Educationvtesimplified
 
Management of colorectal cancer
Management of colorectal cancer Management of colorectal cancer
Management of colorectal cancer
Mohamed Abdulla
 
Ueda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toonyUeda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toonyueda2015
 
Ueda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toonyUeda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toonyueda2015
 
La enfermedad aterosclerótica en cardiología: particularidades y novedades
La enfermedad aterosclerótica en cardiología: particularidades y novedadesLa enfermedad aterosclerótica en cardiología: particularidades y novedades
La enfermedad aterosclerótica en cardiología: particularidades y novedades
Sociedad Española de Cardiología
 
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabe...
Hypertension and Diabetic Kidney Disease Progression 	 Hypertension and Diabe...Hypertension and Diabetic Kidney Disease Progression 	 Hypertension and Diabe...
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabe...MedicineAndHealthUSA
 
Pharmacology PresentationFINAL.pdf
Pharmacology PresentationFINAL.pdfPharmacology PresentationFINAL.pdf
Pharmacology PresentationFINAL.pdf
molly08082002
 
Role of Radiotherapy in Early Hodgkin's Lymphoma (HL)
Role of Radiotherapy in Early Hodgkin's Lymphoma (HL)Role of Radiotherapy in Early Hodgkin's Lymphoma (HL)
Role of Radiotherapy in Early Hodgkin's Lymphoma (HL)
Prof. Shad Salim Akhtar
 
Ndei Cardiovascular Disease In Diabetes Epidemiology
Ndei Cardiovascular Disease In Diabetes EpidemiologyNdei Cardiovascular Disease In Diabetes Epidemiology
Ndei Cardiovascular Disease In Diabetes Epidemiology
david7s
 
Landi F. Valutazione del Geriatric Assessment. ASMaD 2015
Landi F. Valutazione del Geriatric Assessment. ASMaD 2015Landi F. Valutazione del Geriatric Assessment. ASMaD 2015
Landi F. Valutazione del Geriatric Assessment. ASMaD 2015Gianfranco Tammaro
 
Riesgo Cardiovascular en el paciente VIH
Riesgo Cardiovascular en el paciente VIHRiesgo Cardiovascular en el paciente VIH
Riesgo Cardiovascular en el paciente VIH
Medint81
 
Anemo 2014 - Lorusso - ESA nel paziente oncologico
Anemo 2014 - Lorusso - ESA nel paziente oncologicoAnemo 2014 - Lorusso - ESA nel paziente oncologico
Anemo 2014 - Lorusso - ESA nel paziente oncologico
anemo_site
 
Prostate cancer nemrock 2015 sanofi
Prostate cancer nemrock 2015   sanofiProstate cancer nemrock 2015   sanofi
Prostate cancer nemrock 2015 sanofiMohamed Abdulla
 

Similar to Vit D Disease incidence prev chart 051317 (20)

Vit D Chart booklet may2016
Vit D Chart booklet may2016Vit D Chart booklet may2016
Vit D Chart booklet may2016
 
Vit D Mrip chart-booklet-08-2018
Vit D Mrip chart-booklet-08-2018Vit D Mrip chart-booklet-08-2018
Vit D Mrip chart-booklet-08-2018
 
Differences in clinical characteristics and its effect for outcomes
Differences in clinical characteristics and its effect for outcomesDifferences in clinical characteristics and its effect for outcomes
Differences in clinical characteristics and its effect for outcomes
 
ueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammedueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammed
 
Update in oncology
Update in oncologyUpdate in oncology
Update in oncology
 
Dyslipidemia -Assessment and management based on evidence
Dyslipidemia -Assessment and management based on evidence  Dyslipidemia -Assessment and management based on evidence
Dyslipidemia -Assessment and management based on evidence
 
Gastrointestinal-Pancreatic NET management
Gastrointestinal-Pancreatic NET managementGastrointestinal-Pancreatic NET management
Gastrointestinal-Pancreatic NET management
 
VTE and Cancer Healthcare Professional Education
VTE and Cancer Healthcare Professional EducationVTE and Cancer Healthcare Professional Education
VTE and Cancer Healthcare Professional Education
 
Management of colorectal cancer
Management of colorectal cancer Management of colorectal cancer
Management of colorectal cancer
 
Ueda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toonyUeda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toony
 
Ueda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toonyUeda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toony
 
La enfermedad aterosclerótica en cardiología: particularidades y novedades
La enfermedad aterosclerótica en cardiología: particularidades y novedadesLa enfermedad aterosclerótica en cardiología: particularidades y novedades
La enfermedad aterosclerótica en cardiología: particularidades y novedades
 
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabe...
Hypertension and Diabetic Kidney Disease Progression 	 Hypertension and Diabe...Hypertension and Diabetic Kidney Disease Progression 	 Hypertension and Diabe...
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabe...
 
Pharmacology PresentationFINAL.pdf
Pharmacology PresentationFINAL.pdfPharmacology PresentationFINAL.pdf
Pharmacology PresentationFINAL.pdf
 
Role of Radiotherapy in Early Hodgkin's Lymphoma (HL)
Role of Radiotherapy in Early Hodgkin's Lymphoma (HL)Role of Radiotherapy in Early Hodgkin's Lymphoma (HL)
Role of Radiotherapy in Early Hodgkin's Lymphoma (HL)
 
Ndei Cardiovascular Disease In Diabetes Epidemiology
Ndei Cardiovascular Disease In Diabetes EpidemiologyNdei Cardiovascular Disease In Diabetes Epidemiology
Ndei Cardiovascular Disease In Diabetes Epidemiology
 
Landi F. Valutazione del Geriatric Assessment. ASMaD 2015
Landi F. Valutazione del Geriatric Assessment. ASMaD 2015Landi F. Valutazione del Geriatric Assessment. ASMaD 2015
Landi F. Valutazione del Geriatric Assessment. ASMaD 2015
 
Riesgo Cardiovascular en el paciente VIH
Riesgo Cardiovascular en el paciente VIHRiesgo Cardiovascular en el paciente VIH
Riesgo Cardiovascular en el paciente VIH
 
Anemo 2014 - Lorusso - ESA nel paziente oncologico
Anemo 2014 - Lorusso - ESA nel paziente oncologicoAnemo 2014 - Lorusso - ESA nel paziente oncologico
Anemo 2014 - Lorusso - ESA nel paziente oncologico
 
Prostate cancer nemrock 2015 sanofi
Prostate cancer nemrock 2015   sanofiProstate cancer nemrock 2015   sanofi
Prostate cancer nemrock 2015 sanofi
 

More from JA Larson

Why therapists are worried about america’s growing mental health crisis the...
Why therapists are worried about america’s growing mental health crisis   the...Why therapists are worried about america’s growing mental health crisis   the...
Why therapists are worried about america’s growing mental health crisis the...
JA Larson
 
Mazon military-hunger-report-april-2021
Mazon military-hunger-report-april-2021Mazon military-hunger-report-april-2021
Mazon military-hunger-report-april-2021
JA Larson
 
Army National guard health
Army National guard healthArmy National guard health
Army National guard health
JA Larson
 
Army reserve health
Army reserve healthArmy reserve health
Army reserve health
JA Larson
 
Army Active duty soldier health
Army Active duty soldier healthArmy Active duty soldier health
Army Active duty soldier health
JA Larson
 
2020 Army Health of the Force EXSUM
2020 Army Health of the Force EXSUM2020 Army Health of the Force EXSUM
2020 Army Health of the Force EXSUM
JA Larson
 
DOD 2020 Health of the Force
DOD 2020 Health of the ForceDOD 2020 Health of the Force
DOD 2020 Health of the Force
JA Larson
 
2020 Army Health of the Force
2020 Army Health of the Force2020 Army Health of the Force
2020 Army Health of the Force
JA Larson
 
Small Arms Lethality variables 1.6e DRAFT
Small Arms Lethality variables 1.6e DRAFTSmall Arms Lethality variables 1.6e DRAFT
Small Arms Lethality variables 1.6e DRAFT
JA Larson
 
2021 Vitamin D in Ireland
2021 Vitamin D in Ireland2021 Vitamin D in Ireland
2021 Vitamin D in Ireland
JA Larson
 
Injury prevention system v2b3 draft
Injury prevention system v2b3 draftInjury prevention system v2b3 draft
Injury prevention system v2b3 draft
JA Larson
 
Conex 18
Conex 18Conex 18
Conex 18
JA Larson
 
Vit d covid 19 jan
Vit d covid 19 janVit d covid 19 jan
Vit d covid 19 jan
JA Larson
 
Scotland Vit D
Scotland Vit DScotland Vit D
Scotland Vit D
JA Larson
 
Barlows Pond 2019
Barlows Pond 2019Barlows Pond 2019
Barlows Pond 2019
JA Larson
 
D covid v3a
D covid v3aD covid v3a
D covid v3a
JA Larson
 
D covid alipio tan
D covid alipio tanD covid alipio tan
D covid alipio tan
JA Larson
 
D dosing intervals
D dosing intervalsD dosing intervals
D dosing intervals
JA Larson
 
D, magnesium and b12
D, magnesium and b12D, magnesium and b12
D, magnesium and b12
JA Larson
 
Vieth bones vit d
Vieth bones vit dVieth bones vit d
Vieth bones vit d
JA Larson
 

More from JA Larson (20)

Why therapists are worried about america’s growing mental health crisis the...
Why therapists are worried about america’s growing mental health crisis   the...Why therapists are worried about america’s growing mental health crisis   the...
Why therapists are worried about america’s growing mental health crisis the...
 
Mazon military-hunger-report-april-2021
Mazon military-hunger-report-april-2021Mazon military-hunger-report-april-2021
Mazon military-hunger-report-april-2021
 
Army National guard health
Army National guard healthArmy National guard health
Army National guard health
 
Army reserve health
Army reserve healthArmy reserve health
Army reserve health
 
Army Active duty soldier health
Army Active duty soldier healthArmy Active duty soldier health
Army Active duty soldier health
 
2020 Army Health of the Force EXSUM
2020 Army Health of the Force EXSUM2020 Army Health of the Force EXSUM
2020 Army Health of the Force EXSUM
 
DOD 2020 Health of the Force
DOD 2020 Health of the ForceDOD 2020 Health of the Force
DOD 2020 Health of the Force
 
2020 Army Health of the Force
2020 Army Health of the Force2020 Army Health of the Force
2020 Army Health of the Force
 
Small Arms Lethality variables 1.6e DRAFT
Small Arms Lethality variables 1.6e DRAFTSmall Arms Lethality variables 1.6e DRAFT
Small Arms Lethality variables 1.6e DRAFT
 
2021 Vitamin D in Ireland
2021 Vitamin D in Ireland2021 Vitamin D in Ireland
2021 Vitamin D in Ireland
 
Injury prevention system v2b3 draft
Injury prevention system v2b3 draftInjury prevention system v2b3 draft
Injury prevention system v2b3 draft
 
Conex 18
Conex 18Conex 18
Conex 18
 
Vit d covid 19 jan
Vit d covid 19 janVit d covid 19 jan
Vit d covid 19 jan
 
Scotland Vit D
Scotland Vit DScotland Vit D
Scotland Vit D
 
Barlows Pond 2019
Barlows Pond 2019Barlows Pond 2019
Barlows Pond 2019
 
D covid v3a
D covid v3aD covid v3a
D covid v3a
 
D covid alipio tan
D covid alipio tanD covid alipio tan
D covid alipio tan
 
D dosing intervals
D dosing intervalsD dosing intervals
D dosing intervals
 
D, magnesium and b12
D, magnesium and b12D, magnesium and b12
D, magnesium and b12
 
Vieth bones vit d
Vieth bones vit dVieth bones vit d
Vieth bones vit d
 

Recently uploaded

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 

Recently uploaded (20)

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 

Vit D Disease incidence prev chart 051317

  • 1. Disease Incidence Prevention by Serum 25(OH)D Level Serum 25(OH)D, ng/ml 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42 44 46 48 50 52 54 56 58 60 62 64 66 68 Studies of Individuals Cancers, all combined Breast Cancer X X X X X X X X Ovarian Cancer Colon Cancer X X X X Non-Hodgkins Lymphoma Type 1 Diabetes Fractures, all combined Falls, women Multiple Sclerosis X X X Heart Attack (Men) Natural Experiments Kidney Cancer Endometrial Cancer Rickets X X X X X X X 72% 50% 99% 37% 23% 49% 12% 17% 25% 66% 25% 12% 18% 31% 38% 60% 77% with calcium Legend: All percentages reference a common baseline of 25 ng/ml as shown on the chart. %’s reflect the disease prevention % at the beginning and ending of available data. Example: Breast cancer incidence is reduced by 30% when the serum level is 34 ng/ml vs the baseline of 25 ng/ml. There is an 83% reduction in incidence when the serum level is 50 ng/ml vs the baseline of 25 ng/ml. The x’s in the bars indicate ‘reasonable extrapolations’ from the data but are beyond existing data. References: All Cancers: Lappe JM, et al. Am J Clin Nutr. 2007;85:1586-91. Breast: Garland CF, Gorham ED, Mohr SB, Grant WB, Garland FC. Breast cancer risk according to serum 25-Hydroxyvitamin D: Meta-analysis of Dose-Response (abstract).American Association for Cancer Research Annual Meeting, 2008. Reference serum 25(OH)D was 5 ng/ml. Garland, CF, et al. Amer Assoc Cancer Research Annual Mtg, April 2008,. Colon: Gorham ED, et al. Am J Prev Med. 2007;32:210-6. Diabetes: Hyppönen E, et al. Lancet 2001;358:1500-3. Endometrium: Mohr SB, et al. Prev Med. 2007;45:323-4. Falls: Broe KE, et al. J Am Geriatr Soc. 2007;55:234-9. Fractures: Bischoff-Ferrari HA, et al. JAMA. 2005;293:2257-64. Heart Attack: Giovannucci et al. Arch Intern Med/Vol 168 (No 11) June 9, 2008. Multiple Sclerosis: Munger KL, et al. JAMA. 2006;296:2832-8. Non-Hodgkin’s Lymphoma: Purdue MP, et al. Cancer Causes Control. 2007;18:989-99. Ovary: Tworoger SS, et al. Cancer Epidemiol Biomarkers Prev. 2007;16:783-8. Renal: Mohr SB, et al. Int J Cancer. 2006;119:2705-9. Rickets: Arnaud SB, et al. Pediatrics. 1976 Feb;57(2):221-5. Canadians: Janz T. Pearson C. Vitamin D blood levels of Canadians. Statistics Canada. 2013 January; ISSN 1925-6493. US: Al-khalidi et al., Standardized serum 25-hydroxyvitamin D concentrations are inversely associated with cardiometabolic disease in U.S. adults: a cross-sectional analysis of NHANES, 2001-2010. Nutrition Journal. 2017, 16:16. Tribal Africans: Luxwolda M.F. et al. Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/L. Br J Nutr. 2012 November; 108(9):1557-61. Outdoor Workers: Barger-Lux M.J. Heaney R.P. Effects of Above Average Summer Sun Exposure on Serum 25-Hydroxyvitamin D and Calcium Absorption. J Clin Endocrinol Metab. 2002 November. 87(11):4952-6 33% 54%46% SerumReferenceLevel Chart prepared by: Garland CF, Baggerly CACopyright GrassrootsHealth, 05/11/2017 www.grassrootshealth.net 30% 83% 50% 30% X X X X X X X X 40-60 ng/ml suggested range Serum Level 1 Only Rickets Prevented at 20 ng/ml 2 40-60 ng/ml to Prevent Majority of Diseases 3 US & Canadian Average Outdoor Workers in Late Summer Tribal East Africans